Partially Blind Study to Evaluate Immunogenicity & Safety of GSK Bio's HPV Vaccine 580299 in Healthy Women Aged 9-25 Yrs

Clinical trial NCT00541970 · COMPLETED

Trial details

NCT number: NCT00541970
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Infections, Papillomavirus

Start date: 2007-10-17
Primary completion: 2013-03-18
Enrollment: 961

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.